Cipla Limited
CIPLA
Clasificación en acciones
#1820
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Precio por acción
$14.47
Última sincronización: 2026-10-21
Capitalización bursátil
$11.69B
Cambio (1 día)
-0.94%
Cambio (1 año)
-23.41%
País
IN
Comercio Cipla Limited (CIPLA)
Categoría
Healthcare
Historial del precio de la acción de Cipla Limited (CIPLA)
Precio más alto de cierre: $14.60 el 2026-10-01
Precio más bajo de cierre: $0.61 el 1999-01-01
Precio más bajo de cierre: $0.61 el 1999-01-01
Historial del precio de la acción de Cipla Limited desde 1999 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2026 (TTM) | -7.62% |
| 2025 | -3.98% |
| 2024 | 18.60% |
| 2023 | 9.73% |
| 2022 | 11.40% |
| 2021 | 12.45% |
| 2020 | 63.56% |
| 2019 | -11.32% |
| 2018 | -20.85% |
| 2017 | 10.86% |
| 2016 | -13.38% |
| 2015 | -3.99% |
| 2014 | 59.08% |
| 2013 | -16.32% |
| 2012 | 21.62% |
| 2011 | -22.64% |
| 2010 | 8.98% |
| 2009 | 94.47% |
| 2008 | -26.68% |
| 2007 | -6.96% |
| 2006 | 48.26% |
| 2005 | 38.40% |
| 2004 | 24.79% |
| 2003 | 48.49% |
| 2002 | -23.94% |
| 2001 | 11.29% |
| 2000 | -35.33% |
| 1999 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.31 | 42.59% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
